Diamond BioFund
Overview
A publicly listed, evergreen venture capital fund based in Taiwan that specializes in biotechnology and medical investments. It targets globally competitive opportunities, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. The fund has invested in over 20 biotech startups in Taiwan and abroad.
Portfolio Companies
4
Website
diamondbiofund.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EyeYon Medical | Mar 2021 | Series C | Co-investor |
| Iridium Medical Technology Co., Ltd. | Dec 2015 | VC Round | Lead |
| Syncell | Oct 2023 | Seed | Lead |
| ImmunAdd Inc. | Nov 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Diamond BioFund based?
Diamond BioFund is headquartered in Taipei, Taipei, Taiwan.
When was Diamond BioFund founded?
Founding year information for Diamond BioFund is not publicly available.
How many portfolio companies does Diamond BioFund have?
Diamond BioFund has 4 portfolio companies in Caplight's dataset.
What are some companies in Diamond BioFund's portfolio?
Portfolio companies visible on Caplight include EyeYon Medical, Iridium Medical Technology Co., Ltd., Syncell, ImmunAdd Inc..
What was Diamond BioFund's most recent investment shown here?
Diamond BioFund's most recent investment in this portfolio sample was in ImmunAdd Inc. in 2025.
What sectors does Diamond BioFund focus on?
Diamond BioFund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Diamond BioFund focus on?
Diamond BioFund typically invests at the Early stage.
What is Diamond BioFund's AUM?
Diamond BioFund's assets under management are estimated between $267.0M and $267.0M.